nodes	percent_of_prediction	percent_of_DWPC	metapath
Fingolimod—CYP3A4—Esomeprazole—Barrett's esophagus	0.184	0.397	CbGbCtD
Fingolimod—CYP2D6—Omeprazole—Barrett's esophagus	0.17	0.368	CbGbCtD
Fingolimod—CYP3A4—Omeprazole—Barrett's esophagus	0.108	0.234	CbGbCtD
Fingolimod—S1PR3—smooth muscle tissue—Barrett's esophagus	0.0196	0.181	CbGeAlD
Fingolimod—S1PR1—epithelium—Barrett's esophagus	0.018	0.166	CbGeAlD
Fingolimod—CYP4F2—digestive system—Barrett's esophagus	0.0175	0.162	CbGeAlD
Fingolimod—S1PR1—smooth muscle tissue—Barrett's esophagus	0.0173	0.16	CbGeAlD
Fingolimod—SPHK1—smooth muscle tissue—Barrett's esophagus	0.0171	0.158	CbGeAlD
Fingolimod—CYP4F2—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.0168	0.0731	CbGpPWpGaD
Fingolimod—CYP4F12—digestive system—Barrett's esophagus	0.013	0.12	CbGeAlD
Fingolimod—CYP4F12—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.0128	0.0554	CbGpPWpGaD
Fingolimod—CYP4F12—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.0126	0.0547	CbGpPWpGaD
Fingolimod—CYP4F2—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.011	0.0479	CbGpPWpGaD
Fingolimod—CYP4F2—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.0109	0.0472	CbGpPWpGaD
Fingolimod—CYP4F12—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.0104	0.0449	CbGpPWpGaD
Fingolimod—Visual acuity reduced—Esomeprazole—Barrett's esophagus	0.0093	0.0466	CcSEcCtD
Fingolimod—Visual acuity reduced—Omeprazole—Barrett's esophagus	0.0093	0.0466	CcSEcCtD
Fingolimod—CYP4F2—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.00894	0.0388	CbGpPWpGaD
Fingolimod—S1PR1—S1P1 pathway—PTGS2—Barrett's esophagus	0.00696	0.0302	CbGpPWpGaD
Fingolimod—SPHK1—S1P1 pathway—PTGS2—Barrett's esophagus	0.00616	0.0267	CbGpPWpGaD
Fingolimod—Hepatic enzyme increased—Omeprazole—Barrett's esophagus	0.00585	0.0293	CcSEcCtD
Fingolimod—Hepatic enzyme increased—Esomeprazole—Barrett's esophagus	0.00585	0.0293	CcSEcCtD
Fingolimod—CYP4F12—Biological oxidations—CYP26A1—Barrett's esophagus	0.0055	0.0239	CbGpPWpGaD
Fingolimod—CYP4F12—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.00543	0.0235	CbGpPWpGaD
Fingolimod—CYP4F2—Biological oxidations—CYP26A1—Barrett's esophagus	0.00475	0.0206	CbGpPWpGaD
Fingolimod—CYP4F2—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.00469	0.0203	CbGpPWpGaD
Fingolimod—Gastroenteritis—Omeprazole—Barrett's esophagus	0.00453	0.0227	CcSEcCtD
Fingolimod—Gastroenteritis—Esomeprazole—Barrett's esophagus	0.00453	0.0227	CcSEcCtD
Fingolimod—Migraine—Omeprazole—Barrett's esophagus	0.00395	0.0198	CcSEcCtD
Fingolimod—Migraine—Esomeprazole—Barrett's esophagus	0.00395	0.0198	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Esomeprazole—Barrett's esophagus	0.00362	0.0181	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Omeprazole—Barrett's esophagus	0.00362	0.0181	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Esomeprazole—Barrett's esophagus	0.00354	0.0178	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Omeprazole—Barrett's esophagus	0.00354	0.0178	CcSEcCtD
Fingolimod—Influenza—Esomeprazole—Barrett's esophagus	0.00347	0.0174	CcSEcCtD
Fingolimod—Influenza—Omeprazole—Barrett's esophagus	0.00347	0.0174	CcSEcCtD
Fingolimod—CYP4F2—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.0033	0.0143	CbGpPWpGaD
Fingolimod—Weight decreased—Esomeprazole—Barrett's esophagus	0.00314	0.0157	CcSEcCtD
Fingolimod—Weight decreased—Omeprazole—Barrett's esophagus	0.00314	0.0157	CcSEcCtD
Fingolimod—Infestation NOS—Omeprazole—Barrett's esophagus	0.00309	0.0155	CcSEcCtD
Fingolimod—Infestation—Esomeprazole—Barrett's esophagus	0.00309	0.0155	CcSEcCtD
Fingolimod—Infestation—Omeprazole—Barrett's esophagus	0.00309	0.0155	CcSEcCtD
Fingolimod—Infestation NOS—Esomeprazole—Barrett's esophagus	0.00309	0.0155	CcSEcCtD
Fingolimod—Depression—Omeprazole—Barrett's esophagus	0.00309	0.0155	CcSEcCtD
Fingolimod—Depression—Esomeprazole—Barrett's esophagus	0.00309	0.0155	CcSEcCtD
Fingolimod—Sinusitis—Esomeprazole—Barrett's esophagus	0.0029	0.0146	CcSEcCtD
Fingolimod—Sinusitis—Omeprazole—Barrett's esophagus	0.0029	0.0146	CcSEcCtD
Fingolimod—Bradycardia—Esomeprazole—Barrett's esophagus	0.00283	0.0142	CcSEcCtD
Fingolimod—Bradycardia—Omeprazole—Barrett's esophagus	0.00283	0.0142	CcSEcCtD
Fingolimod—S1PR1—Fc-epsilon receptor I signaling in mast cells—RELA—Barrett's esophagus	0.00282	0.0122	CbGpPWpGaD
Fingolimod—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.00273	0.0137	CcSEcCtD
Fingolimod—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.00273	0.0137	CcSEcCtD
Fingolimod—S1PR4—G alpha (i) signalling events—SST—Barrett's esophagus	0.00265	0.0115	CbGpPWpGaD
Fingolimod—Eye disorder—Omeprazole—Barrett's esophagus	0.0026	0.013	CcSEcCtD
Fingolimod—Eye disorder—Esomeprazole—Barrett's esophagus	0.0026	0.013	CcSEcCtD
Fingolimod—S1PR5—G alpha (i) signalling events—SST—Barrett's esophagus	0.00255	0.0111	CbGpPWpGaD
Fingolimod—S1PR3—G alpha (i) signalling events—SST—Barrett's esophagus	0.00255	0.0111	CbGpPWpGaD
Fingolimod—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.0025	0.0126	CcSEcCtD
Fingolimod—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.0025	0.0126	CcSEcCtD
Fingolimod—SPHK1—Fc-epsilon receptor I signaling in mast cells—RELA—Barrett's esophagus	0.00249	0.0108	CbGpPWpGaD
Fingolimod—Alopecia—Omeprazole—Barrett's esophagus	0.00245	0.0123	CcSEcCtD
Fingolimod—Alopecia—Esomeprazole—Barrett's esophagus	0.00245	0.0123	CcSEcCtD
Fingolimod—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.00245	0.0106	CbGpPWpGaD
Fingolimod—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.00245	0.0106	CbGpPWpGaD
Fingolimod—Mental disorder—Omeprazole—Barrett's esophagus	0.00243	0.0122	CcSEcCtD
Fingolimod—Mental disorder—Esomeprazole—Barrett's esophagus	0.00243	0.0122	CcSEcCtD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.00241	0.0104	CbGpPWpGaD
Fingolimod—Back pain—Omeprazole—Barrett's esophagus	0.00234	0.0117	CcSEcCtD
Fingolimod—Back pain—Esomeprazole—Barrett's esophagus	0.00234	0.0117	CcSEcCtD
Fingolimod—S1PR1—G alpha (i) signalling events—SST—Barrett's esophagus	0.00232	0.01	CbGpPWpGaD
Fingolimod—Vision blurred—Esomeprazole—Barrett's esophagus	0.00228	0.0114	CcSEcCtD
Fingolimod—Vision blurred—Omeprazole—Barrett's esophagus	0.00228	0.0114	CcSEcCtD
Fingolimod—CYP2E1—digestive system—Barrett's esophagus	0.00219	0.0202	CbGeAlD
Fingolimod—Leukopenia—Omeprazole—Barrett's esophagus	0.00216	0.0109	CcSEcCtD
Fingolimod—Leukopenia—Esomeprazole—Barrett's esophagus	0.00216	0.0109	CcSEcCtD
Fingolimod—Palpitations—Omeprazole—Barrett's esophagus	0.00214	0.0107	CcSEcCtD
Fingolimod—Palpitations—Esomeprazole—Barrett's esophagus	0.00214	0.0107	CcSEcCtD
Fingolimod—Cough—Esomeprazole—Barrett's esophagus	0.00211	0.0106	CcSEcCtD
Fingolimod—Cough—Omeprazole—Barrett's esophagus	0.00211	0.0106	CcSEcCtD
Fingolimod—S1PR4—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.00211	0.00914	CbGpPWpGaD
Fingolimod—Hypertension—Esomeprazole—Barrett's esophagus	0.00209	0.0105	CcSEcCtD
Fingolimod—Hypertension—Omeprazole—Barrett's esophagus	0.00209	0.0105	CcSEcCtD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.00207	0.00897	CbGpPWpGaD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.00204	0.0102	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.00204	0.0102	CcSEcCtD
Fingolimod—CYP2E1—Vitamin A and Carotenoid Metabolism—CYP26A1—Barrett's esophagus	0.00203	0.00881	CbGpPWpGaD
Fingolimod—S1PR3—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.00203	0.00879	CbGpPWpGaD
Fingolimod—S1PR5—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.00203	0.00879	CbGpPWpGaD
Fingolimod—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.00198	0.00859	CbGpPWpGaD
Fingolimod—Infection—Esomeprazole—Barrett's esophagus	0.00196	0.00983	CcSEcCtD
Fingolimod—Infection—Omeprazole—Barrett's esophagus	0.00196	0.00983	CcSEcCtD
Fingolimod—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.00194	0.0097	CcSEcCtD
Fingolimod—Nervous system disorder—Omeprazole—Barrett's esophagus	0.00194	0.0097	CcSEcCtD
Fingolimod—Skin disorder—Omeprazole—Barrett's esophagus	0.00192	0.00961	CcSEcCtD
Fingolimod—Skin disorder—Esomeprazole—Barrett's esophagus	0.00192	0.00961	CcSEcCtD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.00184	0.00799	CbGpPWpGaD
Fingolimod—Paraesthesia—Esomeprazole—Barrett's esophagus	0.00177	0.00888	CcSEcCtD
Fingolimod—Paraesthesia—Omeprazole—Barrett's esophagus	0.00177	0.00888	CcSEcCtD
Fingolimod—CYP3A4—digestive system—Barrett's esophagus	0.00176	0.0163	CbGeAlD
Fingolimod—Dyspnoea—Omeprazole—Barrett's esophagus	0.00176	0.00882	CcSEcCtD
Fingolimod—Dyspnoea—Esomeprazole—Barrett's esophagus	0.00176	0.00882	CcSEcCtD
Fingolimod—CYP2D6—digestive system—Barrett's esophagus	0.00173	0.016	CbGeAlD
Fingolimod—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.0017	0.00854	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.0017	0.00854	CcSEcCtD
Fingolimod—Fatigue—Esomeprazole—Barrett's esophagus	0.0017	0.00853	CcSEcCtD
Fingolimod—Fatigue—Omeprazole—Barrett's esophagus	0.0017	0.00853	CcSEcCtD
Fingolimod—S1PR4—GPCR ligand binding—SST—Barrett's esophagus	0.0016	0.00696	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of proteins—CDX2—Barrett's esophagus	0.00159	0.00691	CbGpPWpGaD
Fingolimod—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.00156	0.00675	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—SST—Barrett's esophagus	0.00154	0.0067	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—SST—Barrett's esophagus	0.00154	0.0067	CbGpPWpGaD
Fingolimod—CYP2E1—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.00154	0.00666	CbGpPWpGaD
Fingolimod—Asthenia—Esomeprazole—Barrett's esophagus	0.00142	0.0071	CcSEcCtD
Fingolimod—Asthenia—Omeprazole—Barrett's esophagus	0.00142	0.0071	CcSEcCtD
Fingolimod—S1PR1—GPCR ligand binding—SST—Barrett's esophagus	0.0014	0.00608	CbGpPWpGaD
Fingolimod—Pruritus—Omeprazole—Barrett's esophagus	0.0014	0.007	CcSEcCtD
Fingolimod—Pruritus—Esomeprazole—Barrett's esophagus	0.0014	0.007	CcSEcCtD
Fingolimod—Diarrhoea—Esomeprazole—Barrett's esophagus	0.00135	0.00677	CcSEcCtD
Fingolimod—Diarrhoea—Omeprazole—Barrett's esophagus	0.00135	0.00677	CcSEcCtD
Fingolimod—S1PR4—GPCR downstream signaling—GAST—Barrett's esophagus	0.00132	0.00574	CbGpPWpGaD
Fingolimod—Dizziness—Omeprazole—Barrett's esophagus	0.0013	0.00654	CcSEcCtD
Fingolimod—Dizziness—Esomeprazole—Barrett's esophagus	0.0013	0.00654	CcSEcCtD
Fingolimod—S1PR5—GPCR downstream signaling—GAST—Barrett's esophagus	0.00127	0.00552	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—GAST—Barrett's esophagus	0.00127	0.00552	CbGpPWpGaD
Fingolimod—CYP2E1—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.00126	0.00547	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—PTGES—Barrett's esophagus	0.00124	0.00539	CbGpPWpGaD
Fingolimod—Headache—Esomeprazole—Barrett's esophagus	0.00124	0.0062	CcSEcCtD
Fingolimod—Headache—Omeprazole—Barrett's esophagus	0.00124	0.0062	CcSEcCtD
Fingolimod—S1PR4—Signaling by GPCR—GAST—Barrett's esophagus	0.0012	0.00521	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—GAST—Barrett's esophagus	0.00116	0.00501	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—GAST—Barrett's esophagus	0.00116	0.00501	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—GAST—Barrett's esophagus	0.00116	0.00501	CbGpPWpGaD
Fingolimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.00114	0.00493	CbGpPWpGaD
Fingolimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.00114	0.00493	CbGpPWpGaD
Fingolimod—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.0011	0.00479	CbGpPWpGaD
Fingolimod—CYP2D6—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.00109	0.00473	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PTGES—Barrett's esophagus	0.00107	0.00465	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—GAST—Barrett's esophagus	0.00105	0.00455	CbGpPWpGaD
Fingolimod—S1PR4—G alpha (i) signalling events—CXCL8—Barrett's esophagus	0.00103	0.00448	CbGpPWpGaD
Fingolimod—S1PR5—G alpha (i) signalling events—CXCL8—Barrett's esophagus	0.000994	0.00431	CbGpPWpGaD
Fingolimod—S1PR3—G alpha (i) signalling events—CXCL8—Barrett's esophagus	0.000994	0.00431	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—CYP26A1—Barrett's esophagus	0.000941	0.00408	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PTGES—Barrett's esophagus	0.000921	0.004	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—SST—Barrett's esophagus	0.000906	0.00393	CbGpPWpGaD
Fingolimod—S1PR1—G alpha (i) signalling events—CXCL8—Barrett's esophagus	0.000902	0.00391	CbGpPWpGaD
Fingolimod—CYP2D6—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000895	0.00388	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—SST—Barrett's esophagus	0.000873	0.00378	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—SST—Barrett's esophagus	0.000873	0.00378	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—SST—Barrett's esophagus	0.000823	0.00357	CbGpPWpGaD
Fingolimod—S1PR4—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	0.000821	0.00356	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—CYP26A1—Barrett's esophagus	0.000813	0.00352	CbGpPWpGaD
Fingolimod—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000807	0.0035	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—SST—Barrett's esophagus	0.000792	0.00344	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—SST—Barrett's esophagus	0.000792	0.00344	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—SST—Barrett's esophagus	0.000792	0.00344	CbGpPWpGaD
Fingolimod—S1PR3—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	0.00079	0.00343	CbGpPWpGaD
Fingolimod—S1PR5—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	0.00079	0.00343	CbGpPWpGaD
Fingolimod—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	0.000789	0.00342	CbGpPWpGaD
Fingolimod—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000722	0.00313	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—SST—Barrett's esophagus	0.00072	0.00312	CbGpPWpGaD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	0.000717	0.00311	CbGpPWpGaD
Fingolimod—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000713	0.00309	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—GAST—Barrett's esophagus	0.00071	0.00308	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—CYP26A1—Barrett's esophagus	0.000698	0.00303	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—GAST—Barrett's esophagus	0.000683	0.00296	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—GAST—Barrett's esophagus	0.000683	0.00296	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—SLC9A1—Barrett's esophagus	0.000679	0.00294	CbGpPWpGaD
Fingolimod—CYP2E1—Biological oxidations—CYP26A1—Barrett's esophagus	0.00067	0.00291	CbGpPWpGaD
Fingolimod—CYP2E1—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000661	0.00287	CbGpPWpGaD
Fingolimod—S1PR4—GPCR ligand binding—CXCL8—Barrett's esophagus	0.000625	0.00271	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—GAST—Barrett's esophagus	0.00062	0.00269	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—CXCL8—Barrett's esophagus	0.000602	0.00261	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—CXCL8—Barrett's esophagus	0.000602	0.00261	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	0.0006	0.0026	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—SLC9A1—Barrett's esophagus	0.000586	0.00254	CbGpPWpGaD
Fingolimod—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000585	0.00254	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—GAST—Barrett's esophagus	0.000549	0.00238	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—CXCL8—Barrett's esophagus	0.000546	0.00237	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	0.000516	0.00224	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—SLC9A1—Barrett's esophagus	0.000503	0.00218	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—SST—Barrett's esophagus	0.000486	0.00211	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—CYP26A1—Barrett's esophagus	0.000476	0.00206	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	0.000472	0.00205	CbGpPWpGaD
Fingolimod—CYP2D6—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000469	0.00203	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—SST—Barrett's esophagus	0.000468	0.00203	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—SST—Barrett's esophagus	0.000468	0.00203	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—SST—Barrett's esophagus	0.000425	0.00184	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	0.000406	0.00176	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—SST—Barrett's esophagus	0.000376	0.00163	CbGpPWpGaD
Fingolimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000374	0.00162	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—CXCL8—Barrett's esophagus	0.000353	0.00153	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of proteins—CXCL8—Barrett's esophagus	0.00034	0.00147	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—CXCL8—Barrett's esophagus	0.00034	0.00147	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—CXCL8—Barrett's esophagus	0.00034	0.00147	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—CXCL8—Barrett's esophagus	0.000321	0.00139	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	0.000311	0.00135	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—PPARG—Barrett's esophagus	0.00031	0.00134	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—CXCL8—Barrett's esophagus	0.000309	0.00134	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—CXCL8—Barrett's esophagus	0.000309	0.00134	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—CXCL8—Barrett's esophagus	0.000309	0.00134	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000307	0.00133	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—CXCL8—Barrett's esophagus	0.00028	0.00122	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PPARG—Barrett's esophagus	0.000267	0.00116	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—APC—Barrett's esophagus	0.000257	0.00112	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—APC—Barrett's esophagus	0.000248	0.00107	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—APC—Barrett's esophagus	0.000248	0.00107	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—PTGS2—Barrett's esophagus	0.000244	0.00106	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PPARG—Barrett's esophagus	0.00023	0.000996	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—APC—Barrett's esophagus	0.000225	0.000975	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PTGS2—Barrett's esophagus	0.00021	0.000912	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—RELA—Barrett's esophagus	0.000201	0.000872	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—APC—Barrett's esophagus	0.000199	0.000863	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—RELA—Barrett's esophagus	0.000194	0.000839	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—RELA—Barrett's esophagus	0.000194	0.000839	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CXCL8—Barrett's esophagus	0.000189	0.000822	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CXCL8—Barrett's esophagus	0.000182	0.000791	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CXCL8—Barrett's esophagus	0.000182	0.000791	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PTGS2—Barrett's esophagus	0.000181	0.000784	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—RELA—Barrett's esophagus	0.000176	0.000762	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CXCL8—Barrett's esophagus	0.000166	0.000718	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—RELA—Barrett's esophagus	0.000156	0.000675	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PTGES—Barrett's esophagus	0.000151	0.000656	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CXCL8—Barrett's esophagus	0.000147	0.000636	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—TP53—Barrett's esophagus	0.000116	0.000504	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYP26A1—Barrett's esophagus	0.000115	0.000497	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TP53—Barrett's esophagus	0.000112	0.000485	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TP53—Barrett's esophagus	0.000112	0.000485	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PTGES—Barrett's esophagus	0.000107	0.000465	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TP53—Barrett's esophagus	0.000102	0.000441	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TP53—Barrett's esophagus	8.99e-05	0.00039	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—SLC9A1—Barrett's esophagus	8.26e-05	0.000358	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP26A1—Barrett's esophagus	8.13e-05	0.000353	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PTGES—Barrett's esophagus	7.02e-05	0.000304	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SLC9A1—Barrett's esophagus	5.86e-05	0.000254	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	5.32e-05	0.000231	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	3.83e-05	0.000166	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PPARG—Barrett's esophagus	3.77e-05	0.000164	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PTGS2—Barrett's esophagus	2.97e-05	0.000129	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PPARG—Barrett's esophagus	2.68e-05	0.000116	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PTGS2—Barrett's esophagus	2.11e-05	9.13e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PPARG—Barrett's esophagus	1.75e-05	7.59e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	1.38e-05	5.97e-05	CbGpPWpGaD
